Document Detail


Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.
MedLine Citation:
PMID:  20616089     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The number of memory CD8 T cells generated by infection or vaccination correlates strongly with the degree of protection observed in infection and tumor models. Therefore, rapid induction of protective numbers of effector and memory CD8 T cells may be crucial in the case of malignancy, pandemic infection, or bioterrorism. Many studies have shown that amplifying T-cell numbers by prime-boost vaccination is most effective with a substantial time interval between immunizations. In contrast, immunization with peptide-coated mature dendritic cells (DCs) results in a CD8 T-cell response exhibiting accelerated acquisition of memory characteristics, including the ability to respond to booster immunization within days of initial priming. However, personalized DC immunization is too costly, labor intensive, and time-consuming for large-scale vaccination. Here, we demonstrate that in vivo cross-priming with cell-associated antigens or antigen-coated, biodegradable microspheres in the absence of adjuvant quickly generates CD8 T cells that display the phenotype and function of long-term memory populations. Importantly, cross-primed CD8 T cells can respond to booster immunization within days of the initial immunization to generate rapidly large numbers of effector and memory T cells that can protect against bacterial, viral, and parasitic infections, including lethal influenza and malaria-causing Plasmodium infection. Thus, accelerated CD8 T-cell memory after in vivo cross-priming in the absence of adjuvant is generalizable and can be exploited to generate protective immunity rapidly.
Authors:
Nhat-Long L Pham; Lecia L Pewe; Courtney J Fleenor; Ryan A Langlois; Kevin L Legge; Vladimir P Badovinac; John T Harty
Related Documents :
17032169 - Attenuation of cytokine responsiveness during t cell development and differentiation.
20300179 - Immune requirements of post-exposure immunization with modified vaccinia ankara of leth...
20483719 - Fusion proteins for versatile antigen targeting to cell surface receptors reveal differ...
16020689 - Immune responses and disease enhancement during respiratory syncytial virus infection.
9680139 - Abundant ifn-gamma production by local t cells in respiratory syncytial virus-induced e...
20414189 - Multicolor flow cytometry analyses of cellular immune response in rhesus macaques.
14683159 - Efficient immunization strategies for computer networks and populations.
17032169 - Attenuation of cytokine responsiveness during t cell development and differentiation.
7698649 - Growth factor modulation of p53-mediated growth arrest versus apoptosis.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-06-21
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  107     ISSN:  1091-6490     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-09     Completed Date:  2010-08-30     Revised Date:  2011-11-21    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  12198-203     Citation Subset:  IM    
Affiliation:
Departments of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
CD8-Positive T-Lymphocytes / cytology,  immunology*,  metabolism
Cross-Priming / immunology*
Dendritic Cells / immunology
Immunity / immunology*
Immunization / methods
Immunization, Secondary
Immunologic Memory / immunology*
Leukocytes, Mononuclear / immunology
Listeria monocytogenes / immunology
Listeriosis / immunology,  microbiology
Malaria / immunology,  parasitology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Transgenic
Models, Immunological
Ovalbumin / immunology
Plasmodium berghei / immunology
Time Factors
Grant Support
ID/Acronym/Agency:
AI150073/AI/NIAID NIH HHS; AI42767/AI/NIAID NIH HHS; AI46653/AI/NIAID NIH HHS; AI83286/AI/NIAID NIH HHS; R01 AI050073-10/AI/NIAID NIH HHS; R37 AI042767-14/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
9006-59-1/Ovalbumin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence from an emerging sign language reveals that language supports spatial cognition.
Next Document:  Metabolic cost as a unifying principle governing neuronal biophysics.